Fly News Breaks for March 6, 2015
ASPX
Mar 6, 2015 | 07:52 EDT
Stifel hiked its price target on Auspex after speaking with an expert neuropsychiatrist. Following its discussions with the expert, the firm is more confident in the addressable market opportunity for Auspex's TBZ drug and the likelihood of the stock rising on near-term catalysts. The firm keeps a Buy rating on the shares.
News For ASPX From the Last 2 Days
There are no results for your query ASPX